(JRVR) James River Holdings - Overview
Stock: Excess, Surplus, Liability, Property, Fronting
| Risk 5d forecast | |
|---|---|
| Volatility | 51.3% |
| Relative Tail Risk | -12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 29.63 |
| Character TTM | |
|---|---|
| Beta | 0.878 |
| Beta Downside | 1.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.17% |
| CAGR/Max DD | -0.40 |
EPS (Earnings per Share)
Revenue
Description: JRVR James River Holdings February 26, 2026
James River Group Holdings, Inc. (NASDAQ: JRVR) is a specialty insurer operating two primary segments: Excess and Surplus Lines, which underwrites liability and property coverage across the United States, Puerto Rico, and the U.S. Virgin Islands via wholesale brokers; and Specialty Admitted Insurance, which supplies fronting, program administration, and managing general agent solutions. Founded in 2002 and based in Chapel Hill, NC, the firm focuses on niche markets that larger carriers often avoid.
In its most recent fiscal quarter (Q3 2024), JRVR reported net written premium of $124 million, a 9% year-over-year increase, and a combined ratio of 94.2%, indicating underwriting profitability. The company posted adjusted earnings per share of $0.38 and a market capitalization of approximately $1.1 billion, reflecting steady investor confidence in its specialized business model.
The property-and-casualty sector is currently driven by rising insurance rates tied to inflation, heightened natural-catastrophe exposure, and a hardening market cycle that favors surplus-lines carriers. JRVR’s focus on wholesale distribution and niche admitted lines positions it to capture premium growth as commercial clients seek tailored coverage amid these macro-economic pressures.
For a deeper dive into JRVR’s valuation and risk profile, you might explore the analysis tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -49.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 5.65 > 1.0 |
| NWC/Revenue: -319.4% < 20% (prev 446.7%; Δ -766.1% < -1%) |
| CFO/TA 0.00 > 3% & CFO 15.5m > Net Income -49.4m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago 22.65% < -2% |
| Gross Margin: 15.83% > 18% (prev 0.48%; Δ 1536 % > 0.5%) |
| Asset Turnover: 13.05% > 50% (prev 14.07%; Δ -1.02% > 0%) |
| Interest Coverage Ratio: -0.99 > 6 (EBITDA TTM -22.6m / Interest Expense TTM 23.3m) |
Altman Z'' -3.13
| A: -0.42 (Total Current Assets 1.79b - Total Current Liabilities 3.85b) / Total Assets 4.95b |
| B: -0.08 (Retained Earnings -394.4m / Total Assets 4.95b) |
| C: -0.00 (EBIT TTM -23.0m / Avg Total Assets 4.95b) |
| D: -0.10 (Book Value of Equity -433.4m / Total Liabilities 4.31b) |
| Altman-Z'' Score: -3.13 = D |
Beneish M -0.69
| DSRI: 1.10 (Receivables 2.31b/2.28b, Revenue 646.6m/697.8m) |
| GMI: 3.02 (GM 15.83% / 47.76%) |
| AQI: 1.84 (AQ_t 0.64 / AQ_t-1 0.35) |
| SGI: 0.93 (Revenue 646.6m / 697.8m) |
| TATA: -0.01 (NI -49.4m - CFO 15.5m) / TA 4.95b) |
| Beneish M-Score: -0.69 (Cap -4..+1) = D |
What is the price of JRVR shares?
Over the past week, the price has changed by +1.31%, over one month by +3.27%, over three months by +18.00% and over the past year by +46.28%.
Is JRVR a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JRVR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.3 | 5.6% |
| Analysts Target Price | 7.3 | 5.6% |
JRVR Fundamental Data Overview February 27, 2026
P/S = 0.4713
P/B = 0.5174
Revenue TTM = 646.6m USD
EBIT TTM = -23.0m USD
EBITDA TTM = -22.6m USD
Long Term Debt = 329.9m USD (from longTermDebt, last quarter)
Short Term Debt = 3.15m USD (from shortTermDebt, last fiscal year)
Debt = 329.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 91.1m USD (from netDebt column, last quarter)
Enterprise Value = -291.5m USD (304.8m + Debt 329.9m - CCE 926.2m)
Interest Coverage Ratio = -0.99 (Ebit TTM -23.0m / Interest Expense TTM 23.3m)
EV/FCF = -28.03x (Enterprise Value -291.5m / FCF TTM 10.4m)
FCF Yield = -3.57% (FCF TTM 10.4m / Enterprise Value -291.5m)
FCF Margin = 1.61% (FCF TTM 10.4m / Revenue TTM 646.6m)
Net Margin = -7.64% (Net Income TTM -49.4m / Revenue TTM 646.6m)
Gross Margin = 15.83% ((Revenue TTM 646.6m - Cost of Revenue TTM 544.2m) / Revenue TTM)
Gross Margin QoQ = 21.10% (prev 25.34%)
Tobins Q-Ratio = -0.06 (set to none) (Enterprise Value -291.5m / Total Assets 4.95b)
Interest Expense / Debt = 1.89% (Interest Expense 6.22m / Debt 329.9m)
Taxrate = 39.93% (1.06m / 2.65m)
NOPAT = -13.8m (EBIT -23.0m * (1 - 39.93%)) [loss with tax shield]
Current Ratio = 0.46 (Total Current Assets 1.79b / Total Current Liabilities 3.85b)
Debt / Equity = 0.52 (Debt 329.9m / totalStockholderEquity, last quarter 636.8m)
Debt / EBITDA = -4.02 (negative EBITDA) (Net Debt 91.1m / EBITDA -22.6m)
Debt / FCF = 8.76 (Net Debt 91.1m / FCF TTM 10.4m)
Total Stockholder Equity = 618.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.00% (Net Income -49.4m / Total Assets 4.95b)
RoE = -7.99% (Net Income TTM -49.4m / Total Stockholder Equity 618.5m)
RoCE = -2.43% (EBIT -23.0m / Capital Employed (Equity 618.5m + L.T.Debt 329.9m))
RoIC = -1.71% (negative operating profit) (NOPAT -13.8m / Invested Capital 809.0m)
WACC = 4.98% (E(304.8m)/V(634.6m) * Re(9.15%) + D(329.9m)/V(634.6m) * Rd(1.89%) * (1-Tc(0.40)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.08%
[DCF] Terminal Value 80.82% ; FCFF base≈10.4m ; Y1≈6.83m ; Y5≈3.12m
[DCF] Fair Price = 0.18 (EV 99.3m - Net Debt 91.1m = Equity 8.17m / Shares 46.0m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -51.48 | EPS CAGR: -7.86% | SUE: -1.13 | # QB: 0
Revenue Correlation: -44.18 | Revenue CAGR: -4.75% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.20 | Chg7d=+0.013 | Chg30d=+0.013 | Revisions Net=-1 | Growth EPS=+1.4% | Growth Revenue=-1.0%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)